rediff.com
e.g. Tata motors, Reliance MF, 500570
BSE | NSE

AstraZeneca Pharma India Ltd.

506820 ASTRAZEN Group (A)

03 Jul,15:28
6362.80
-3.85 (-0.06%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Mkt Cap (Rs. Cr)

AstraZeneca Pharma India Ltd.

BUYSELL

637 6,366.65 6,511.00 - 6,349.60 7,208.00 - 3,650.05 15,907.00
NSE | BSE

AstraZeneca Pharma India Ltd.

ASTRAZEN

03 Jul,15:42
6398.10
34.20 (0.54%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Turnover (Rs. Lacs)

AstraZeneca Pharma India Ltd.

BUYSELL

15,550 6363.90 6,514.90 - 6,350.00 7,220.95 - 3,698.05 100,158,327.50

News for AstraZeneca Pharma India Ltd.

AstraZeneca...
AstraZeneca Withdraws COVID Vaccine: Surplus of Updated Vaccines
AstraZeneca is globally withdrawing its COVID-19 vaccine, Covishield, due to a surplus of newer vaccines and declining demand. The company highlights the vaccine's significant role in combating the...
May 08, 2024 14:34
AstraZeneca...
AstraZeneca Withdraws COVID-19 Vaccine: Surplus of Updated Shots
AstraZeneca has withdrawn its COVID-19 vaccine globally due to a surplus of updated vaccines. The company cites a decline in demand for Vaxzevria, which was sold as Covishield in India.
May 08, 2024 11:12
Covaxin Safe, No...
Covaxin Safe, No Side Effects: Bharat Biotech
Bharat Biotech assures Covaxin is safe and effective, with no reported side effects like blood clots, unlike Covishield. Developed with safety as priority, it was rigorously tested.
May 02, 2024 21:41
Lupin Gets USFDA...
Lupin Gets USFDA Approval for Generic Diabetes Drug
Lupin receives USFDA approval to market a generic version of AstraZeneca's Qtern tablets, a medication for type 2 diabetes. The drug will be manufactured at Lupin's Pithampur facility.
Jan 04, 2024 19:17
Lupin Gets USFDA...
Lupin Gets USFDA Approval for Generic Diabetes Drug
Lupin has received USFDA approval to market a generic medication for type 2 diabetes, a generic equivalent of AstraZeneca's Qtern tablets. The drug will be manufactured at Lupin's Pithampur facility.
Jan 04, 2024 19:12

More News for AstraZeneca Pharma India Ltd. »

(Rs. Crore)

Financial Results of AstraZeneca Pharma India Ltd.

Mar ' 24Mar ' 23Mar ' 22Mar ' 21Mar ' 20
Sales1,295.531,002.97805.60813.56831.81
Operating profit184.45165.1386.17135.47120.69
Interest1.200.630.951.091.14
Gross profit218.05190.5999.99147.22132.54
EPS (Rs)64.6039.7224.6437.3228.88

See more in Research Center »

News for Pharmaceuticals and health care

GM to Pay $146M...
GM to Pay $146M for Excess CO2 Emissions from Older Vehicles
General Motors will pay $146 million in penalties for 5.9 million vehicles failing to meet fuel economy standards. The affected models include Chevy Tahoe, Cadillac Escalade, and Chevy Silverado.
Jul 03, 2024 22:39
GPAI Reaches...
GPAI Reaches Consensus on Future Vision
The GPAI Ministerial Council has agreed on a future vision for the partnership, recognizing AI's potential and addressing emerging risks and challenges.
Jul 03, 2024 22:25
Indiabulls...
Indiabulls Housing Finance Rebrands to Sammaan Capital
Indiabulls Housing Finance has officially changed its name to Sammaan Capital. The company will transition its branding over the coming month.
Jul 03, 2024 22:12
Bharat Coal...
Bharat Coal Gasification Project: Pre-Bid Meeting Held
Bharat Coal Gasification & Chemicals Ltd (BCGCL) holds pre-bid meeting for its first coal gasification project in Odisha, aiming to finalize the detailed feasibility report.
Jul 03, 2024 22:04
Writesonic &...
Writesonic & Microsoft Partner for Enterprise AI Solutions
Writesonic, a generative AI platform, has partnered with Microsoft to offer enhanced AI-powered solutions for enterprises, leveraging Azure's cloud infrastructure for scalability and security.
Jul 03, 2024 21:40

More News »

Top News

GM to Pay $146M...
GM to Pay $146M for Excess CO2 Emissions from Older Vehicles
General Motors will pay $146 million in penalties for 5.9 million vehicles failing to meet fuel economy standards. The affected models include Chevy Tahoe, Cadillac Escalade, and Chevy Silverado.
Jul 03, 2024 22:39
GPAI Reaches...
GPAI Reaches Consensus on Future Vision
The GPAI Ministerial Council has agreed on a future vision for the partnership, recognizing AI's potential and addressing emerging risks and challenges.
Jul 03, 2024 22:25
Indiabulls...
Indiabulls Housing Finance Rebrands to Sammaan Capital
Indiabulls Housing Finance has officially changed its name to Sammaan Capital. The company will transition its branding over the coming month.
Jul 03, 2024 22:12
Bharat Coal...
Bharat Coal Gasification Project: Pre-Bid Meeting Held
Bharat Coal Gasification & Chemicals Ltd (BCGCL) holds pre-bid meeting for its first coal gasification project in Odisha, aiming to finalize the detailed feasibility report.
Jul 03, 2024 22:04
Writesonic &...
Writesonic & Microsoft Partner for Enterprise AI Solutions
Writesonic, a generative AI platform, has partnered with Microsoft to offer enhanced AI-powered solutions for enterprises, leveraging Azure's cloud infrastructure for scalability and security.
Jul 03, 2024 21:40

More Top News »

Report Card

PE Ratios
98.85
EPS (Rs.)
64.60
Sales (Rs. Cr)
383.20
Face Value (Rs.)
2
Net Profit Margin (%)
9.89
Last Bonus
1:1
Last Dividend(%)
1200
Return on Average Equity
16.86

BSE Announcements from AstraZeneca Pharma India Ltd. (See all)

announcement Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate - 6 day(s) ago
announcement Record Date For Payment Of Final Dividend - 25 Jun 2024

Compare 'AstraZeneca Pharma India Ltd.' with other stocks

  • Sun Pharmaceutical Industries Ltd.
  • 1,517.90
  • Compare
  • Divi's Laboratories Ltd.
  • 4,599.90
  • Compare
  • Zydus Lifesciences Ltd.
  • 1,066.95
  • Compare
  • Dr. Reddy's Laboratories Ltd.
  • 6,351.50
  • Compare
  • Torrent Pharmaceuticals Ltd.
  • 2,779.40
  • Compare
  • Max Healthcare Institute Ltd.
  • 955.05
  • Compare
  • Apollo Hospitals Enterprise Ltd.
  • 6,137.05
  • Compare
  • Alkem Laboratories Ltd.
  • 4,956.50
  • Compare

AstraZeneca Pharma India Ltd. performance snapshot

If you had invested Rs.  in AstraZeneca Pharma India Ltd.,     ago

You would have  Rs. 000.00 

Add to Portfolio
Close
Add AstraZeneca Pharma India Ltd. to your Portfolio
 
 
BSE NSE  
 
Close
Add AstraZeneca Pharma India Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close